132 related articles for article (PubMed ID: 34928543)
1. BCL10 correlates with bad prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
Chen H; Li Z; Wu F; Ji W; Lu L; Wu Z; Huang Y; Wang W; Li S
IUBMB Life; 2023 Mar; 75(3):207-224. PubMed ID: 34928543
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Key Genes Combining with Immune Infiltration Level and Tumor Mutational Burden in Hepatocellular Carcinoma.
Chen J; Zhang L; Lu CH; Xu CZ
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38213141
[TBL] [Abstract][Full Text] [Related]
3. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Li L; Wang X; Ding Y; Hui N; Su B; Yang M
Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
[TBL] [Abstract][Full Text] [Related]
4. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma.
Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Front Immunol; 2022; 13():831101. PubMed ID: 35371079
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.
Xu J; Shen X; Zhang B; Su R; Cui M; Yan L; Cao Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34386813
[TBL] [Abstract][Full Text] [Related]
8. METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment.
Wang L; Peng JL
Sci Rep; 2023 Jul; 13(1):10755. PubMed ID: 37400463
[TBL] [Abstract][Full Text] [Related]
9. High MCM8 expression correlates with unfavorable prognosis and induces immune cell infiltration in hepatocellular carcinoma.
Yu M; Wang H; Xu H; Lv Y; Li Q
Aging (Albany NY); 2022 Dec; 14(24):10027-10049. PubMed ID: 36575045
[TBL] [Abstract][Full Text] [Related]
10. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
11. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
12. Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma.
Chen Y; Tang L; Huang W; Abisola FH; Zhang Y; Zhang G; Yao L
Biol Direct; 2023 Feb; 18(1):4. PubMed ID: 36750831
[TBL] [Abstract][Full Text] [Related]
13.
Peng Q; Li J; Wu Q; Wang P; Kang Z; Deng Y; Xiao Y; Zheng P; Ge F; Chen Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834567
[TBL] [Abstract][Full Text] [Related]
14. SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration.
Shen W; Yuan L; Cheng F; Wu Z; Li X
Genes Genomics; 2024 Jan; 46(1):49-64. PubMed ID: 37985547
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
16. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
[TBL] [Abstract][Full Text] [Related]
17. RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma.
Li H; Gao L; Kang X; Wang X; Yu Y; Zhang Y; Chen H
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614249
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma.
Wang M; Yang X; Meng Y; Jin Z; Cao J; Xiong L; Xiong Z
Int Immunopharmacol; 2023 Feb; 115():109660. PubMed ID: 36623412
[TBL] [Abstract][Full Text] [Related]
19. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
Yin Z; Ma T; Chen S; Yu M
Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
[TBL] [Abstract][Full Text] [Related]
20. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
